11 results
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... commonly used diabetic ... #pharmacology #dm2 ... #diabetes #medications ... overview #management #comparison
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #medications #table ... #comparison #management ... endocrinology #dm2
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... anti-hyperglycemic agents ... manage Type 2 diabetes ... pharmacotherapy #table ... #comparison #management
Summary of Non-Insulin Agents Used to Treat Diabetes

#Diabetes #Pharmacology #Comparison #Table #Medications #Noninsulin #Orals #Agents
of Non-Insulin Agents ... Used to Treat Diabetes ... #Diabetes #Pharmacology ... #Comparison #Table ... Noninsulin #Orals #Agents
Key Characteristics of Old and New Potassium-Binding Agents

- Dr. Edgar V. Lerma https://twitter.com/edgarvlermamd

#Potassium #Binding #KBinders #Kayexelate
New Potassium-Binding ... Agents - Dr. ... #Potassium #Binding ... KBinders #Kayexelate #Comparison ... #Table #Pharmacology
Warfarin and DOAC Pharmacology
Warfarin - Dabigatran - Rivaroxaban - Apixaban - Edoxaban
Target - Prodrug - Bioavailability
Target - Prodrug - Bioavailability ... Plasma Protein Binding ... Pharmacology #NOAC #comparison ... #table #dabigatran
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... insulin in Type 1 Diabetes ... #Mellitus #DM2 ... #pharmacology #comparison ... #table #endocrinology
Table 22 provides the characteristics of various phosphate-binding agents.
#Pharmacology #Nephrology #Phosphate #Phosphorus #Binders #Comparison #Table #Disadvantages
Table 22 provides ... various phosphate-binding ... agents. ... Phosphorus #Binders #Comparison ... #Table #Disadvantages
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding ... Agents to Treat ... aspiration #Potassium #Binding ... #pharmacology #table ... #comparison #binders
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Any adverse events ... Insulin dependent DM ... event, follow ACC algorithm ... Diabetes regimen ... postoperative cardiac events